7 results match your criteria: "PD Hinduja Hospital and Research Centre[Affiliation]"
JAMA Netw Open
August 2024
School of Psychology I Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.
Importance: The role of olanzapine has not been adequately evaluated in moderately emetogenic chemotherapy (MEC) regimens with or without neurokinin-1 receptor antagonists.
Objective: To evaluate whether addition of olanzapine to an MEC regimen reduces nausea, vomiting, and use of nausea rescue medications among patients with solid malignant tumors.
Design, Setting, And Participants: This multicenter, open-label phase 3 randomized clinical trial included patients aged 18 years or older with solid malignant tumors who were receiving oxaliplatin-, carboplatin-, or irinotecan-based chemotherapy.
J Assoc Physicians India
December 2023
Consultant Nephrologist and Transplant Physician, Lancelot Kidney and GI Centre, Mumbai, Maharashtra, India.
Background: Obesity, prediabetes, and type 2 diabetes mellitus (T2DM) pose a triple burden in India. Almost two-thirds of people with diabetes (PWD) in India are found to have suboptimal glycemic, blood pressure, and lipid control. Medical nutrition therapy (MNT) in diabetes has emphasized on the amount and type of carbohydrates for years.
View Article and Find Full Text PDFIndian J Nephrol
September 2021
University of Pittsburgh Medical Center, Pittsburgh, USA.
Indian J Endocrinol Metab
July 2021
Department of Endocrinology and Diabetes, Max Healthcare, Saket, Press Enclave Road, New Delhi, India.
Pediatr Infect Dis J
September 2019
Department of Microbiology, PD Hinduja Hospital and Research Centre, Mumbai, Maharashtra, India.
Isolated cases of septicemia associated with probiotics have been reported. We describe Bacillus clausii septicemia in a 4-month-old male infant with congenital heart disease following treatment for diarrhea with a probiotic containing B. clausii spores.
View Article and Find Full Text PDFJ Glob Oncol
July 2018
Supriya Chopra, Ashwathy Mathew, Amita Maheshwari, Shylasree T. Surappa, Jaya Ghosh, Kedar Deodhar, Palak Popat, Umesh Mahantshetty, Reena Engineer, Jyoti Bajpai, Bharat Rekhi, Aruna Alihari, Santosh Menon, Sneha Shah, Seema Gulia, Lavanya Naidu, Meenakshi Thakur, Venkatesh Rangrajan, Rajendra Kerkar, Sudeep Gupta, and Shyam K. Shrivastava, Tata Memorial Centre; Hemant Tongaonkar, PD Hinduja Hospital and Research Centre; Yogesh Kulkarni, Kokilaben Dhirubhai Ambani Hospital, Mumbai; Neerja Bhatla and Dayanand Sharma, All India Institute of Medical Oncology, New Delhi; Shalini Singh, Sanjay Gandhi Postgraduate Institute, Lucknow; Bhawana Rai, Postgraduate Institute of Medical Education and Research, Chandigarh; Jaydip Bhaumik, Tata Medical Centre, Kolkata; Manash Biswas, Roorkee Army Hospital, Roorkee; Sushil Giri, Acharya Hariharan Regional Cancer Centre, Cuttack; Ramesh Billimaga, HCG Hospital; Govind Babu, Kidwai Institute of Oncology, Bangalore; Abraham Pedicayil and Sidhanna Palled, Christian Medical College, Vellore; Rajkumar Thangrajan, Cancer Institute Adyar, Chennai, India; Surbhi Grover, University of Pennsylvania, Philadelphia, PA; and Surbhi Grover, Princess Marina Hospital, Gaborone, Botswana.
Standard guidelines for the management of early and locally advanced cervical cancer are available from various academic consortiums nationally and internationally. However, implementing standard-of-care treatment poses unique challenges within low- and middle-income countries, such as India, where diverse clinical care practices may exist. The National Cancer Grid, a consortium of 108 institutions in India, aims to homogenize care for patients with cervical cancer by achieving consensus on not only imaging and management, but also in addressing potential solutions to prevalent challenges that affect the homogenous implementation of standard-of-care treatment.
View Article and Find Full Text PDFIndian Pediatr
August 2017
Departments of Pediatrics, *Pediatric Neurology and #Neurosurgery, PD Hinduja Hospital and Research Centre, Mumbai, India. Correspondence to: Dr Neelu Desai, Pediatric Neurologist, PD Hinduja Hospital and MRC, Veer Savarkar Marg, Mahim, Mumbai 400 016, India.
Background: Management of refractory status epilepticus in children is extremely challenging.
Case Characteristics: Two children with medically refractory status epilepticus, both of whom had lesional pathology on MRI and concordant data on EEG and PET scan.
Intervention: Emergency hemispherotomy performed in both patients.